课题基金 / 基金详情

STUDY ON THE ROLE OF Na_+-H_+ EXCHANGE ON ISCHEMIA-REPERFUSION INjURY

STUDY ON THE ROLE OF Na_+-H_+ EXCHANGE ON ISCHEMIA-REPERFUSION INjURY
Na_-H_交换对缺血再灌注损伤作用的研究
批准号:
07670816
负责人:
WAKIDA Yasushi
金额:
$1.47万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1995
资助国家:
日本
项目状态:
已结题
起止时间:
1995 至 1997

项目摘要

项目成果

WAKIDA Yasushi的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The inhibition of Na<@D1+@>D1-H<@D1+@>D1 exchange (NHE) with amiloride analogues in vitro has been shown to prevent reperfusion arrythmias and additional cell necrosis. Inhibition of intracellular Ca<@D12+@>D1 overload via NHE inhibition has been suggested as a mechanism of these protective effects. The aim of this study was to examine whether treatment with amiloride analogues reduces the incidence of reperfusion arrythmias and limits infarct size in vivo. Open-chest swine were exposed to a 30 min left anterior descending artery occlusion and 180 min reperfusion during atrial pacing at 150 ppm. In protocol 1, intravenous 5-(N,N-dimethyl)-amiloride (AML) 5mug/kg/min was administered 10 min before coronary occlusion in the treatment group (n=7) and intravenous saline in the control group (n=7). In protocol 2, an intravenous bolus injection of AML 1mg/kg was performed 5 min before reperfusion and followed by 5mug/kg/min intravenous injection in the treatment group (n=7) and saline in the … More control group (n=8). There was no significant difference in the size of the area at risk and hemodynamic parameters between the treatment ans control groups both in the protocols. However, the infarcted area was 0.4(]SY.+-。[)1.0% of the area at risk in the treatment group of the protocol 1, whereas it was 62(]SY.+-。[)29% in the control group (p<0.05). The infarcted area in the treatment group of the protocol 2 was also significantly smaller than that in the control group (10.3(]SY.+-。[)7.1% vs.42.3(]SY.+-。[)18.8%, p<0.05). Pathological examination revealed that all of the infarcted area consisted of contraction band necrosis. There was no significant difference in the incidence of ventricular arrhythmias after reperfusion between the groups in the protocols. Inhibition of NHE with AML prevented reperfusion related cell necrosis in the in vivo swine model. This effect was augmented if the drug was administered before ischemia. However, even if the drug was administered after ischemia (before reperfusion), there was significant reduction of the infarcted area. In this experimental model, there was no effect on reperfusion arrhythmia in the both protocols. Less
期刊论文(9)
专著(0)
科研奖励(0)
会议论文
Uesugi M., Wakida Y., Fukuta M., Watabe K., Iwa T., Kobayashi T.: "of Na^+-H^+ Exchange Inhibitor Administrated Before Reperfusion Reduces Myocardial Necrosis in Open Chest Swine Model" XIXth Congress of the European Society of Cardiology. Stockholm Swede
Uesugi M.、Wakida Y.、Fukuta M.、Watabe K.、Iwa T.、Kobayashi T.:“再灌注前施用 Na^ -H^ 交换抑制剂可减少开胸猪模型中的心肌坏死”第十九届欧洲大会
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
福田 元敬: "虚血再灌流障害におけるNa^+-H^+exchange inbibitor の関与について" 愛知医科大学医学会雑誌. 24. 579-587 (1996)
Mototaka Fukuda:“Na^+-H^+交换抑制剂参与缺血再灌注损伤”爱知医科大学医学会杂志 24. 579-587 (1996)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Motokuki Fukuta: "Role of Na^+-H^+ Exchange Inhibitor on Ischemia-reperfusion Injury" J.Aichi.Med.Univ.Assoc. 24. 579-587 (1996)
Motokuki Fukuta:“Na^ -H^ 交换抑制剂对缺血再灌注损伤的作用”J.Aichi.Med.Univ.Assoc。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Motouki Fukuta, Yasushi Wakida, Toru Iwa, Michitaka Uesugi, Tadashi Kobayashi.: "Role of Na^+-H^+ Exchange on Reperfusion Related Myocardial Injury and Arrhythmias in an Open-Chest Swine Model" PACE. 19[Pt.II]. 2027-2033 (1996)
Motouki Fukuta、Yasushi Wakida、Toru Iwa、Michitaka Uesugi、Tadashi Kobayashi。:“开胸猪模型中 Na^ -H^ 交换对再灌注相关心肌损伤和心律失常的作用”PACE。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
9
    Local Drug Delivery of ONO-4007 Inhibits Neointimal Hyperplasia in Dogs.
    • 批准号:
      10670680
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $1.98万
    • 财政年份:
      1998
    • 负责人:
      WAKIDA Yasushi
    • 依托单位:
    海外基金